Global Thematic Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Global Thematic Partners’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-225,125	Closed	-$18.1M	–	84
2015 Q3	$18.1M	Sell	225,125 -7,495	-3%	-$833K	0.3%	68
2015 Q2	$27.9M	Sell	232,620 -152,714	-40%	-$18.3M	0.37%	66
2015 Q1	$40.2M	Sell	385,334 -20,465	-5%	-$2.07M	0.6%	54
2014 Q4	$39.4M	Sell	405,799 -3,804	-0.9%	-$352K	0.62%	50
2014 Q3	$32M	Sell	409,603 -4,022	-1%	-$259K	0.48%	63
2014 Q2	$26.1M	Sell	413,625 -12,697	-3%	-$755K	0.4%	62
2014 Q1	$28.6M	Buy	+426,322	New	+$33M	0.47%	55

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Global Thematic Partners's ALNY Position: Q4 2015 in Review

Global Thematic Partners sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2015, closing a stake of 225,125 shares — an estimated $18.1M sold.

Global Thematic Partners first reported a position in ALNY in Q1 2014 and held it in 7 quarters. The position peaked at $40.2M in Q1 2015. 261 funds tracked by Wall St. Rank hold ALNY as of Q4 2015.

Global Thematic Partners reported no remaining Alnylam Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Global Thematic Partners sold 225,125 Alnylam Pharmaceuticals shares in Q4 2015, an estimated $18.1M.
Global Thematic Partners first reported a position in Alnylam Pharmaceuticals in Q1 2014 and held it in 7 quarters.
Global Thematic Partners's Alnylam Pharmaceuticals position peaked at $40.2M in Q1 2015.
261 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2015.

Based on Global Thematic Partners's 13F filing for Q4 2015, filed 26 Jan 2016.